These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 15988069)

  • 1. Analysis of dimerization determinants of PDE6 catalytic subunits.
    Muradov KG; Boyd KK; Artemyev NO
    Methods Mol Biol; 2005; 307():263-75. PubMed ID: 15988069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions between catalytic and inhibitory subunits of PDE6.
    Artemyev NO
    Methods Mol Biol; 2005; 307():277-88. PubMed ID: 15988070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The GAFa domains of rod cGMP-phosphodiesterase 6 determine the selectivity of the enzyme dimerization.
    Muradov KG; Boyd KK; Martinez SE; Beavo JA; Artemyev NO
    J Biol Chem; 2003 Mar; 278(12):10594-601. PubMed ID: 12531898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclic guanosine 5'-monophosphate binding to regulatory GAF domains of photoreceptor phosphodiesterase.
    Cote RH
    Methods Mol Biol; 2005; 307():141-54. PubMed ID: 15988061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of 3',5' cyclic nucleotide phosphodiesterase activity in Y79 retinoblastoma cells: absence of functional PDE6.
    White JB; Thompson WJ; Pittler SJ
    Mol Vis; 2004 Oct; 10():738-49. PubMed ID: 15480303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of photoreceptor PDE (PDE6): similarities and differences to PDE5.
    Cote RH
    Int J Impot Res; 2004 Jun; 16 Suppl 1():S28-33. PubMed ID: 15224133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutation in rod PDE6 linked to congenital stationary night blindness impairs the enzyme inhibition by its gamma-subunit.
    Muradov KG; Granovsky AE; Artemyev NO
    Biochemistry; 2003 Mar; 42(11):3305-10. PubMed ID: 12641462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural determinants of the PDE6 GAF A domain for binding the inhibitory gamma-subunit and noncatalytic cGMP.
    Muradov H; Boyd KK; Artemyev NO
    Vision Res; 2004; 44(21):2437-44. PubMed ID: 15358079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Asymmetric interaction between rod cyclic GMP phosphodiesterase gamma subunits and alphabeta subunits.
    Guo LW; Grant JE; Hajipour AR; Muradov H; Arbabian M; Artemyev NO; Ruoho AE
    J Biol Chem; 2005 Apr; 280(13):12585-92. PubMed ID: 15668239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A 46-amino acid segment in phosphodiesterase-5 GAF-B domain provides for high vardenafil potency over sildenafil and tadalafil and is involved in phosphodiesterase-5 dimerization.
    Blount MA; Zoraghi R; Ke H; Bessay EP; Corbin JD; Francis SH
    Mol Pharmacol; 2006 Nov; 70(5):1822-31. PubMed ID: 16926278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular organization of bovine rod cGMP-phosphodiesterase 6.
    Kameni Tcheudji JF; Lebeau L; Virmaux N; Maftei CG; Cote RH; Lugnier C; Schultz P
    J Mol Biol; 2001 Jul; 310(4):781-91. PubMed ID: 11453687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential inhibitor sensitivity between human recombinant and native photoreceptor cGMP-phosphodiesterases (PDE6s).
    Zhang J; Kuvelkar R; Wu P; Egan RW; Billah MM; Wang P
    Biochem Pharmacol; 2004 Sep; 68(5):867-73. PubMed ID: 15294449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ligand-induced conformational changes in cyclic nucleotide phosphodiesterases and cyclic nucleotide-dependent protein kinases.
    Francis SH; Chu DM; Thomas MK; Beasley A; Grimes K; Busch JL; Turko IV; Haik TL; Corbin JD
    Methods; 1998 Jan; 14(1):81-92. PubMed ID: 9500860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three-dimensional structure of non-activated cGMP phosphodiesterase 6 and comparison of its image with those of activated forms.
    Kajimura N; Yamazaki M; Morikawa K; Yamazaki A; Mayanagi K
    J Struct Biol; 2002 Jul; 139(1):27-38. PubMed ID: 12372317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of the gamma subunit-interacting residues on photoreceptor cGMP phosphodiesterase, PDE6alpha '.
    Granovsky AE; Artemyev NO
    J Biol Chem; 2000 Dec; 275(52):41258-62. PubMed ID: 11024033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural determinants for inhibitor specificity and selectivity in PDE2A using the wheat germ in vitro translation system.
    Iffland A; Kohls D; Low S; Luan J; Zhang Y; Kothe M; Cao Q; Kamath AV; Ding YH; Ellenberger T
    Biochemistry; 2005 Jun; 44(23):8312-25. PubMed ID: 15938621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of PDE6 function using chimeric PDE5/6 catalytic domains.
    Muradov H; Boyd KK; Artemyev NO
    Vision Res; 2006 Mar; 46(6-7):860-8. PubMed ID: 16256165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification, reconstitution on lipid vesicles, and assays of PDE6 and its activator G protein, transducin.
    Wensel TG; He F; Malinski JA
    Methods Mol Biol; 2005; 307():289-313. PubMed ID: 15988071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystallization of cyclic nucleotide phosphodiesterases.
    Ke H; Huai Q; Xu RX
    Methods Mol Biol; 2005; 307():181-90. PubMed ID: 15988064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purification of PDE6 isozymes from mammalian retina.
    Pentia DC; Hosier S; Collupy RA; Valeriani BA; Cote RH
    Methods Mol Biol; 2005; 307():125-40. PubMed ID: 15988060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.